About Ronald Sugar, Ph.D.
Form D filings for Avenda Health from 2022 to 2024 list Ronald Sugar, Ph.D. as director.
Ronald Sugar, Ph.D. first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Ronald Sugar, Ph.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ronald Sugar, Ph.D. works with at each company, as listed on that company's latest Form D.
Avenda Health, Inc. · Form D/A, Jan 18, 2024
MK
Michael Klein
Director
LD
Leonard Marks, M.D.
Director
SD
Shyam Natarajan, Ph.D.
Chief Executive Officer and director
BD
Brittany Pusey, Ph.D.
Executive officer